Back to VRTX
FOSTER DYKEMA CABOT & PARTNERS, LLC → VRTX
FOSTER DYKEMA CABOT & PARTNERS, LLC VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
5
Latest value
$29.8M
Q3 2026
Peak value
$29.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $23.8M |
| Q4 2025 | $26.5M |
| Q1 2026 | $25.8M |
| Q2 2026 | $28.9M |
| Q3 2026 | $29.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $29.8M | 56.9K | — | — |
| Q2 2026 | $28.9M | 58.2K | — | — |
| Q1 2026 | $25.8M | 57.8K | — | — |
| Q4 2025 | $26.5M | 58.3K | — | — |
| Q3 2025 | $23.8M | 60.7K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B